Over a decade ago, Soderberg and colleagues reported that EVs from melanoma cells transferred TNF-α to recipient T cells, which resulted in elevated ROS levels and the disruption of the activation of CD4+ and CD8+ T cells [109]. This evidence concerns the gene CD8A and melanoma.